EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc Fundamental Analysis
EKF Diagnostics Holdings plc (EKDHF) shows weak financial fundamentals with a PE ratio of 18.53, profit margin of 12.19%, and ROE of 8.50%. The company generates $0.0B in annual revenue with weak year-over-year growth of -4.59%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 42.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze EKDHF's fundamental strength across five key dimensions:
Efficiency Score
WeakEKDHF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentEKDHF trades at attractive valuation levels.
Growth Score
WeakEKDHF faces weak or negative growth trends.
Financial Health Score
ExcellentEKDHF maintains a strong and stable balance sheet.
Profitability Score
WeakEKDHF struggles to sustain strong margins.
Key Financial Metrics
Is EKDHF Expensive or Cheap?
P/E Ratio
EKDHF trades at 18.53 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, EKDHF's PEG of -11.55 indicates potential undervaluation.
Price to Book
The market values EKF Diagnostics Holdings plc at 1.58 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 11.18 times EBITDA. This signals the market has high growth expectations.
How Well Does EKDHF Make Money?
Net Profit Margin
For every $100 in sales, EKF Diagnostics Holdings plc keeps $12.19 as profit after all expenses.
Operating Margin
Core operations generate 13.94 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $8.50 in profit for every $100 of shareholder equity.
ROA
EKF Diagnostics Holdings plc generates $7.42 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
EKF Diagnostics Holdings plc produces operating cash flow of $10.23M, showing steady but balanced cash generation.
Free Cash Flow
EKF Diagnostics Holdings plc generates strong free cash flow of $9.05M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.02 in free cash annually.
FCF Yield
EKDHF converts 8.75% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
18.53
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-11.55
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.58
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.16
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.62
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How EKDHF Stacks Against Its Sector Peers
| Metric | EKDHF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 18.53 | 29.45 | Better (Cheaper) |
| ROE | 8.50% | 779.00% | Weak |
| Net Margin | 12.19% | -24930.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 4.62 | 4.65 | Strong Liquidity |
| ROA | 7.42% | -19333.00% (disorted) | Weak |
EKDHF outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews EKF Diagnostics Holdings plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
11.84%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
69.85%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
167.98%
Industry Style: Defensive, Growth, Innovation
High Growth